![Correlation between prostate specific antigen levels and various prostatic pathologies Banerjee B, Iqbal BM, Kumar H, Kambale T, Bavikar R - J Med Soc Correlation between prostate specific antigen levels and various prostatic pathologies Banerjee B, Iqbal BM, Kumar H, Kambale T, Bavikar R - J Med Soc](https://www.jmedsoc.org/articles/2016/30/3/images/JMedSoc_2016_30_3_172_191184_b1.jpg)
Correlation between prostate specific antigen levels and various prostatic pathologies Banerjee B, Iqbal BM, Kumar H, Kambale T, Bavikar R - J Med Soc
![Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research](https://www.ahajournals.org/cms/asset/cb19e14f-b3bb-4a13-abba-cc81bdf9ac9c/1492fig01.gif)
Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research
![Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/12aed22c0affb1decf9e7953f12f3a9fb0849553/22-Table2-1.png)
Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar
![Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions | Scientific Reports Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-04116-8/MediaObjects/41598_2021_4116_Fig1_HTML.png)
Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions | Scientific Reports
![QuickStats: Percentage of Men Aged <U>></U>40 Years* with Prostate-Specific Antigen (PSA) Levels of <U>></U>2.5 and <U>></U>4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004 QuickStats: Percentage of Men Aged <U>></U>40 Years* with Prostate-Specific Antigen (PSA) Levels of <U>></U>2.5 and <U>></U>4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004](https://www.cdc.gov/mmwr/preview/mmwrhtml/figures/m548qsf.gif)
QuickStats: Percentage of Men Aged <U>></U>40 Years* with Prostate-Specific Antigen (PSA) Levels of <U>></U>2.5 and <U>></U>4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004
![Frontiers | Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer Frontiers | Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer](https://www.frontiersin.org/files/Articles/198354/fonc-06-00157-HTML/image_m/fonc-06-00157-t002.jpg)
Frontiers | Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer
![of cancer stage in patients with prostate cancer according to serum PSA... | Download Scientific Diagram of cancer stage in patients with prostate cancer according to serum PSA... | Download Scientific Diagram](https://www.researchgate.net/publication/313738598/figure/tbl2/AS:614288326672428@1523469158987/of-cancer-stage-in-patients-with-prostate-cancer-according-to-serum-PSA-levels.png)
of cancer stage in patients with prostate cancer according to serum PSA... | Download Scientific Diagram
![Prostate specific antigen (PSA) as a long-term marker of risk for prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK Prostate specific antigen (PSA) as a long-term marker of risk for prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2008/04/newest-lilja-table.png)
Prostate specific antigen (PSA) as a long-term marker of risk for prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
![Spontaneous Progressive Diminution of Prostate-Specific Antigen Levels as a Clue to Secondary Hypogonadism and Ultimately a Pituitary Macroadenoma - ScienceDirect Spontaneous Progressive Diminution of Prostate-Specific Antigen Levels as a Clue to Secondary Hypogonadism and Ultimately a Pituitary Macroadenoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2376060520301127-fx2.jpg)
Spontaneous Progressive Diminution of Prostate-Specific Antigen Levels as a Clue to Secondary Hypogonadism and Ultimately a Pituitary Macroadenoma - ScienceDirect
![Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers](https://img.medscapestatic.com/pi/meds/ckb/07/23507tn.jpg)
Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers
![Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/624cfadd-1edd-4a95-853e-6264e72dfd82/gr1_lrg.jpg)
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t2.jpeg)